Evidence map›Paper›PMID 31164163›Full record

ArticleDiagnostic pathology2019

Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.

Rukun Wang, Gaofeng Li, Guoyan Zhuang, Shuying Sun, Zhihui Song

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rukun WangDepartment of Thoracic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, 261061, Shandong, China.
Gaofeng LiDepartment of Thyroid and Breast Surgery, Weifang Cancer Hospital, Weifang, 261041, Shandong, China.
Guoyan ZhuangDepartment of Outpatient, Weifang Cancer Hospital, Weifang, 261041, Shandong, China.
Shuying SunDepartment of Nursing, Weifang Cancer Hospital, Weifang, 261041, Shandong, China.
Zhihui SongDepartment of Thoracic Surgery, Weifang Cancer Hospital, Weifang, 261041, Shandong, China. qianzhong638939749@163.com.
Weifang Medical University · CNWeifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is one of the common malignant tumors worldwide with high incidence and mortality. MicroRNA-423-3p (miR-423-3p) acts as an oncogene in several types of cancers. The aim of this study is to reveal the clinical significance and biological function of miR-423-3p in lung cancer.

methodsThe expression of miR-423-3p was detected in lung cancer specimens by reverse transcription-quantitative polymerase chain reaction (qRT-PCR) assay. Kaplan-Meier survival and Cox regression analyses were used to investigate the prognostic significance of miR-423-3p in lung cancer. CCK-8 and Transwell assays were used to determine the functional role of miR-423-3p in lung cancer.

resultsWe observed that miR-423-3p was significantly upregulated in lung cancer tissues and cell lines. Overexpression of miR-423-3p was significantly associated with lymph node metastasis, TNM stage, and poor prognosis. Multivariate Cox regression analysis results showed that miR-423-3p was an independent prognostic indicator for lung cancer patients. Results of functional analyses revealed that overexpression of miR-423-3p promoted cell proliferation, migration, and invasion in lung cancer cells.

conclusionsThese results indicated that miR-423-3p acts as an oncogene and promotes cell proliferation migration, and invasion of lung cancer. And miR-423-3p may serve as a potential prognostic biomarker and therapeutic target for the treatment of lung cancer.

Indexed as

Cell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLung NeoplasmsLymphatic MetastasisMaleMicroRNAsMiddle AgedMultivariate AnalysisNeoplasm InvasivenessPrognosisUp-RegulationMicroRNAsMIRN423 microRNA, humanInvasionLung cancermicroRNA-423-3pMigrationPrognosisProliferation

Identifiers

PMID31164163
PMCPMC6549275
OpenAlexW2948289539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.